#USA #diabetes management #Bronx #Montefiore Health System #Continuous Glucose Monitor

Transforming Diabetes Management with Continuous Glucose Monitors

Recent findings from researchers at Montefiore Einstein have unveiled a compelling approach to enhancing diabetes care in primary clinics. Despite the proven efficacy of Continuous Glucose Monitors (CGMs)—a small wearable device that tracks blood sugar levels continuously—only a mere 10% of Americans who require insulin actually use these devices. This stark statistic underscores the necessity for a strategic shift in diabetes management practices.

A Breakthrough in Diabetes Care

In a study recently published in JAMA Network Open, it was highlighted that of over 2,000 patients using CGMs, there was a remarkable 13% reduction in hospital admissions and an 18% decrease in emergency room visits compared to those without CGM. These results have ignited a strong focus on integrating CGMs into primary care practices across 18 clinics within the Montefiore Medical Group, targeting the management of diabetes more effectively.

Dr. Jovan Milosavljevic, the lead author and an endocrinologist at Montefiore Einstein, remarked on the critical need for accessible diabetes management tools, stating, "Over 40 million people in the U.S. live with diabetes, thus collaborative efforts are essential for providing them the necessary resources to manage their condition effectively."

Empowering Primary Care Providers

The initiative to incorporate CGMs in primary care stems from an awareness that many diabetes patients frequent their primary care providers far more often than endocrinologists. By empowering primary care teams with the tools and training needed to use CGMs effectively, the healthcare landscape for diabetes management can be dramatically altered. Dr. Shivani Agarwal, a senior director at Montefiore Einstein, emphasized that transforming care models to fit primary care is essential for promoting better health outcomes. "We need to accelerate the benefits of modern medicine to our patients swiftly to enhance their quality of life and health outcomes," she stated.

Prior to the introduction of CGMs, blood glucose readings were predominantly collected through painful finger pricks, which only conveyed a snapshot of a patient's health at one moment. In contrast, CGMs provide a continuous stream of data, allowing for easier monitoring of blood sugar fluctuations caused by various factors—such as diet, exercise, and medication. This wealth of information enables healthcare providers to engage patients in meaningful discussions regarding their diabetes management and care.

A Comprehensive Approach to Diabetes Management

With backing from the American Diabetes Association, a comprehensive initiative is underway to train doctors on CGM prescription and management. Nurses in clinics are also being educated on the application and activation of these devices for patients. This program encourages patients not only to learn how to manage their glucose levels effectively but also to take an active role in developing the CGM support system within their treatment environment.

Dr. Sybil J. Hodgson noted the shift in treatment discussions made possible by CGMs, stating, "Previously, we'd often base our discussions on one number. Now, with CGMs, we can interrogate specific moments when they experienced fluctuations in their glucose levels and comprehend better how food and lifestyle contribute to their diabetes. This enriches our understanding and enhances treatment decisions based on a plethora of actionable data points."

This transformational model of diabetes management exemplifies how innovation in technology, when combined with compassionate healthcare practices, can dramatically enhance outcomes for those living with diabetes. The Montefiore Health System continues to position itself as a leader in integrated and community-focused healthcare, striving to bring effective treatments to those who need them most.

Conclusion

As the diabetes epidemic continues to challenge populations globally, the adoption of CGMs in primary care represents a promising step forward in patient empowerment and symptom management. The insights from Montefiore's research are paving the way for a reimagined approach to diabetes treatment—one that is not only more effective but also more aligned with the everyday realities of patients' lives.